Literature DB >> 1713201

Analysis of immune responses of different hosts to Babesia divergens isolates from different geographic areas and capacity of culture-derived exoantigens to induce efficient cross-protection.

E Precigout1, A Gorenflot, A Valentin, G Bissuel, B Carcy, P Brasseur, Y Moreau, J Schrevel.   

Abstract

The immunoprecipitation of [35S]methionine-radiolabelled antigens from different Babesia divergens isolates by using bovine, gerbil, and human immune sera has shown that many B. divergens proteins contain epitopes shared between isolates. The cross-protective capacity of culture-derived soluble immunogens from the B. divergens Rouen 1987 isolate was tested against different B. divergens isolates. Results showed complete protection against the 7107b French isolate and substantial protection against the Weybridge 8843 English isolate (80% protection) and the Munich 87 German isolate (60% protection). In order to explain these vaccination results and to assess both the common and variable antigenicity of B. divergens, the antigenic patterns of the challenge isolates (Rouen 1987, 7107b, Weybridge 8843, and Munich 87) were compared by immunoprecipitation, using gerbil antisera raised against the Rouen 1987 vaccine isolate. Differences in the antigenic patterns and in the cross-protection of gerbils in these heterologous challenges were examined by studying the virulence and the antigenic status of each isolate.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1713201      PMCID: PMC258089          DOI: 10.1128/iai.59.8.2799-2805.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Tolerance to imidocarb induced experimentally in tick-transmitted Babesia argentina.

Authors:  R J Dalgliesh; N P Stewart
Journal:  Aust Vet J       Date:  1977-04       Impact factor: 1.281

2.  Identification of Babesia bigemina and Babesia bovis merozoite proteins with isolate- and species-common epitopes recognized by antibodies in bovine immune sera.

Authors:  T F McElwain; G H Palmer; W L Goff; T C McGuire
Journal:  Infect Immun       Date:  1988-06       Impact factor: 3.441

3.  Acquired immunity to Babesia microti and Babesia rodhaini in mice.

Authors:  F E Cox; A S Young
Journal:  Parasitology       Date:  1969-02       Impact factor: 3.234

4.  Infection of the Mongolian gerbil with the cattle piroplasm Babesia divergens.

Authors:  D Lewis; H Williams
Journal:  Nature       Date:  1979-03-08       Impact factor: 49.962

Review 5.  The molecular biology of trypanosomes.

Authors:  P T Englund; S L Hajduk; J C Marini
Journal:  Annu Rev Biochem       Date:  1982       Impact factor: 23.643

6.  Identification of major Babesia divergens polypeptides that induce protection against homologous challenge in gerbils.

Authors:  A Gorenflot; E Precigout; G Bissuel; O Lecointre; P Brasseur; E Vidor; M L'Hostis; J Schrevel
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

7.  Variable and common antigens of Babesia bovis parasites differing in strain and virulence.

Authors:  L P Kahl; R F Anders; B J Rodwell; P Timms; G F Mitchell
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

8.  Babesia bovis: comparison of culture-derived parasites, non-living antigen and conventional vaccine in the protection of cattle against heterologous challenge.

Authors:  P Timms; R J Dalgliesh; D N Barry; C K Dimmock; B J Rodwell
Journal:  Aust Vet J       Date:  1983-03       Impact factor: 1.281

9.  Bovine babesiosis: pathogenicity and heterologous species immunity of tick-borne Babesia bovis and B bigemina infections.

Authors:  R D Smith; E Molinar; F Larios; J Monroy; F Trigo; M Ristic
Journal:  Am J Vet Res       Date:  1980-12       Impact factor: 1.156

10.  Cytological and immunological responses to Babesia divergens in different hosts: ox, gerbil, man.

Authors:  A Gorenflot; P Brasseur; E Precigout; M L'Hostis; A Marchand; J Schrevel
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

View more
  5 in total

1.  Antibodies raised against Bcvir15, an extrachromosomal double-stranded RNA-encoded protein from Babesia canis, inhibit the in vitro growth of the parasite.

Authors:  P Drakulovski; B Carcy; K Moubri; C Carret; D Depoix; T P M Schetters; A Gorenflot
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

Review 2.  Babesia divergens, a bovine blood parasite of veterinary and zoonotic importance.

Authors:  Annetta Zintl; Grace Mulcahy; Helen E Skerrett; Stuart M Taylor; Jeremy S Gray
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

3.  Cellular and humoral immune responses induced in cattle by vaccination with Babesia divergens culture-derived exoantigens correlate with protection.

Authors:  A Valentin; E Precigout; M L'Hostis; B Carcy; A Gorenflot; J Schrevel
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

4.  3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors lovastatin and simvastatin inhibit in vitro development of Plasmodium falciparum and Babesia divergens in human erythrocytes.

Authors:  P Grellier; A Valentin; V Millerioux; J Schrevel; D Rigomier
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

5.  A 37-kilodalton glycoprotein of Babesia divergens is a major component of a protective fraction containing low-molecular-mass culture-derived exoantigens.

Authors:  B Carcy; E Precigout; A Valentin; A Gorenflot; J Schrevel
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.